Skip to main content
Premium Trial:

Request an Annual Quote

Link Technologies Signs China Distribution Deal

NEW YORK (GenomeWeb News) – Link Technologies today announced that it has signed on Zirench Technology to be its distributor in China.

Zirench is based in Dalian City, China, and is the firm's first Asian distributor. Bellshill, Scotland-based Link said that it plans to sign multiple distribution agreements in the Far East.

"We are working hard to effectively deliver our products to customers in research and industrial institutions in Asia and other parts of the world, where easily accessible local support and expertise is very important," Link Technologies CEO John Bremner said in a statement.

Link sells specialty reagents for oligonucleotide synthesis and modification.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.